Post-market Study of the Biodesign Hernia Graft

Stopped early

Conditions studied: Ventral Hernia

In brief

The purpose of this study is to collect data on the performance of the Biodesign® Hernia Graft when used to reinforce soft tissues during ventral hernia repair.

Key facts

Study ID

NCT04294446

Run by

Cook Biotech Incorporated

People needed

74

Starts

2020-11-10

Expected to finish

2024-11-26

Last updated by the study team

2026-03-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Primary or recurrent ventral hernia in need of surgical repair utilizing a Biodesign Hernia Graft

You may not qualify if…

• Known sensitivity to porcine material
• For the study, the following patients will also be excluded:
• Age < 18 years
• Unable or unwilling to provide informed consent
• Life expectancy of less than one year from the date of the index procedure
• Patients will be excluded from the study if they never receive a Biodesign Hernia Graft during their index procedure.

Where it is running

• Vanderbilt University Medical Center — Nashville, Tennessee, United States
• St. Paul's Hospital — Vancouver, British Columbia, Canada
• Queen Elizabeth II Hospital — Halifax, Nova Scotia, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.